Waters Research and Development Expenses 2010-2025 | WAT
Waters annual/quarterly research and development expenses history and growth rate from 2010 to 2025. Research and development expenses can be defined as an expense arising from studies and product development processes.
- Waters research and development expenses for the quarter ending March 31, 2025 were $0.047B, a 4.55% increase year-over-year.
- Waters research and development expenses for the twelve months ending March 31, 2025 were $0.185B, a 4.64% increase year-over-year.
- Waters annual research and development expenses for 2024 were $0.183B, a 4.62% increase from 2023.
- Waters annual research and development expenses for 2023 were $0.175B, a 0.71% decline from 2022.
- Waters annual research and development expenses for 2022 were $0.176B, a 4.65% increase from 2021.
| Waters Annual Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2024 | $183 |
| 2023 | $175 |
| 2022 | $176 |
| 2021 | $168 |
| 2020 | $141 |
| 2019 | $143 |
| 2018 | $143 |
| 2017 | $133 |
| 2016 | $125 |
| 2015 | $119 |
| 2014 | $108 |
| 2013 | $101 |
| 2012 | $96 |
| 2011 | $92 |
| 2010 | $84 |
| 2009 | $77 |
| Waters Quarterly Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2025-03-31 | $47 |
| 2024-12-31 | $47 |
| 2024-09-30 | $45 |
| 2024-06-30 | $46 |
| 2024-03-31 | $45 |
| 2023-12-31 | $44 |
| 2023-09-30 | $42 |
| 2023-06-30 | $46 |
| 2023-03-31 | $43 |
| 2022-12-31 | $48 |
| 2022-09-30 | $43 |
| 2022-06-30 | $44 |
| 2022-03-31 | $40 |
| 2021-12-31 | $43 |
| 2021-09-30 | $42 |
| 2021-06-30 | $45 |
| 2021-03-31 | $38 |
| 2020-12-31 | $40 |
| 2020-09-30 | $35 |
| 2020-06-30 | $31 |
| 2020-03-31 | $35 |
| 2019-12-31 | $37 |
| 2019-09-30 | $34 |
| 2019-06-30 | $36 |
| 2019-03-31 | $35 |
| 2018-12-31 | $38 |
| 2018-09-30 | $35 |
| 2018-06-30 | $36 |
| 2018-03-31 | $34 |
| 2017-12-31 | $35 |
| 2017-09-30 | $34 |
| 2017-06-30 | $33 |
| 2017-03-31 | $31 |
| 2016-12-31 | $33 |
| 2016-09-30 | $30 |
| 2016-06-30 | $33 |
| 2016-03-31 | $29 |
| 2015-12-31 | $28 |
| 2015-09-30 | $31 |
| 2015-06-30 | $31 |
| 2015-03-31 | $29 |
| 2014-12-31 | $29 |
| 2014-09-30 | $27 |
| 2014-06-30 | $27 |
| 2014-03-31 | $25 |
| 2013-12-31 | $27 |
| 2013-09-30 | $24 |
| 2013-06-30 | $25 |
| 2013-03-31 | $25 |
| 2012-12-31 | $25 |
| 2012-09-30 | $24 |
| 2012-06-30 | $24 |
| 2012-03-31 | $23 |
| 2011-12-31 | $24 |
| 2011-09-30 | $23 |
| 2011-06-30 | $23 |
| 2011-03-31 | $22 |
| 2010-12-31 | $23 |
| 2010-09-30 | $21 |
| 2010-06-30 | $21 |
| 2010-03-31 | $20 |
| 2009-12-31 | $20 |
| 2009-09-30 | $19 |
| 2009-06-30 | $20 |
| 2009-03-31 | $18 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $16.761B | $2.958B |
| Waters Corp. is an analytical instrument manufacturer and offers practical and sustainable products for laboratory-dependent organizations. Moreover, Waters provides analytical workflow solutions based on mass spectrometry (MS), liquid chromatography (LC) and thermal analysis technologies. The company's products are used by pharmaceutical, life science, biochemical, industrial, academic and government customers, working in research and development, quality assurance and other laboratory applications. The company operates in Asia, Americas and Europe. Waters organizes its business into two operating segments: Waters Division and TA Division. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $184.987B | 81.02 |
| Thermo Fisher Scientific (TMO) | United States | $152.862B | 18.49 |
| Edwards Lifesciences (EW) | United States | $44.910B | 29.45 |
| Alcon (ALC) | Switzerland | $42.991B | 29.05 |
| IDEXX Laboratories (IDXX) | United States | $41.889B | 48.14 |
| DexCom (DXCM) | United States | $32.949B | 50.93 |
| IQVIA Holdings (IQV) | United States | $27.500B | 15.40 |
| Mettler-Toledo (MTD) | United States | $24.243B | 28.83 |
| STERIS (STE) | Ireland | $21.902B | 24.12 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.211B | 0.00 |
| Hologic (HOLX) | United States | $14.193B | 15.42 |
| Sysmex ADR (SSMXY) | Japan | $10.525B | 29.86 |
| Penumbra (PEN) | United States | $8.863B | 69.56 |
| Masimo (MASI) | United States | $8.411B | 31.03 |
| Globus Medical (GMED) | United States | $7.025B | 16.74 |
| Glaukos (GKOS) | United States | $5.527B | 0.00 |
| Teleflex (TFX) | United States | $4.852B | 8.01 |
| Integer Holdings (ITGR) | United States | $3.892B | 20.39 |
| TransMedics (TMDX) | United States | $3.505B | 76.18 |
| PROCEPT BioRobotics (PRCT) | United States | $3.157B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.309B | 13.75 |
| Nihon Kohden (NHNKY) | Japan | $2.170B | 24.88 |
| Elekta AB (EKTAY) | Sweden | $1.887B | 16.97 |
| Veracyte (VCYT) | United States | $1.804B | 25.31 |
| Alphatec Holdings (ATEC) | United States | $1.506B | 0.00 |
| Artivion (AORT) | United States | $1.308B | 122.56 |
| OPKO Health (OPK) | United States | $1.110B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.007B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $0.974B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.884B | 4.70 |
| IRadimed (IRMD) | United States | $0.714B | 36.25 |
| SiBone (SIBN) | United States | $0.710B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.620B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.547B | 11.77 |
| OrthoPediatrics (KIDS) | United States | $0.531B | 0.00 |
| AxoGen (AXGN) | United States | $0.529B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.527B | 8.19 |
| Pacific Biosciences Of California (PACB) | United States | $0.435B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.418B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.394B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.374B | 8.69 |
| AngioDynamics (ANGO) | United States | $0.365B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.360B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.307B | 0.00 |
| NeuroPace (NPCE) | United States | $0.307B | 0.00 |
| RxSight (RXST) | United States | $0.299B | 0.00 |
| Neuronetics (STIM) | United States | $0.257B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.253B | 0.00 |
| 908 Devices (MASS) | United States | $0.250B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.225B | 13.61 |
| CVRx (CVRX) | United States | $0.216B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.203B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.177B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.171B | 0.00 |
| Inogen (INGN) | United States | $0.169B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.157B | 0.00 |
| LENSAR (LNSR) | United States | $0.157B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.149B | 0.00 |
| Accuray (ARAY) | United States | $0.138B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.120B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.110B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.108B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.089B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.087B | 0.00 |
| InspireMD (NSPR) | United States | $0.077B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.076B | 46.00 |
| Hyperfine (HYPR) | United States | $0.075B | 0.00 |
| Spectral AI (MDAI) | United States | $0.062B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.061B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.057B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.056B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.051B | 20.78 |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| Envoy Medical (COCH) | United States | $0.034B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.024B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.020B | 0.00 | |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.009B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.007B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.02 |